Related references
Note: Only part of the references are listed.The pathology of scleroderma vascular disease
Jo Nadine Fleming et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2008)
Vascular endothelial growth factor and its relationship to inflammatory mediators
Laura S. Angelo et al.
CLINICAL CANCER RESEARCH (2007)
Systemic sclerosis: a prototypic multisystem fibrotic disorder
John Varga et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
VEGF controls endothelial-cell permeability by promoting the β-arrestin-dependent endocytosis of VE-cadherin
Julie Gavard et al.
NATURE CELL BIOLOGY (2006)
The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis
CA Davies et al.
HUMAN PATHOLOGY (2006)
Effect of specimen anticoagulation on the measurement of circulating platelet-derived growth factors
R Zimmermann et al.
CLINICAL CHEMISTRY (2005)
Scleroderma: from cell and molecular mechanisms to disease models
DJ Abraham et al.
TRENDS IN IMMUNOLOGY (2005)
Endothelial/pericyte interactions
A Armulik et al.
CIRCULATION RESEARCH (2005)
Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis
O Distler et al.
CIRCULATION RESEARCH (2004)
Molecular regulation of vessel maturation
RK Jain
NATURE MEDICINE (2003)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Angiogenesis in health and disease
P Carmeliet
NATURE MEDICINE (2003)
Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being
TA Medsger
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2003)
Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy
Y Dor et al.
EMBO JOURNAL (2002)
Aerosolized iloprost induces a mild but sustained inhibition of platelet aggregation
M Beghetti et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers
O Distler et al.
ARTHRITIS RESEARCH (2002)
Systemic sclerosils-related Raynaud's phenomenon: Effects of iloprost infusion therapy on serum cytokine, growth factor and soluble adhesion molecule levels
M Mittag et al.
ACTA DERMATO-VENEREOLOGICA (2001)
Share Paper
